Hualan Bio Subsidiary Receives GMP Certification For Hepatitis B Vaccine
This article was originally published in PharmAsia News
Executive Summary
Hualan Bio's share price jumped 6 percent to RMB 53.10 per share Sep. 10, following an announcement on GMP certification for a subsidiary's hepatitis B vaccine production facility